Diazepam - OptMed

Drug Profile

Diazepam - OptMed

Alternative Names: Re-purposed Diazepam - OptMed

Latest Information Update: 08 Nov 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator OptMed
  • Class Antiepileptic drugs; Anxiolytics; Benzodiazepines; Benzodiazepinones; Hypnosedatives; Muscle relaxants; Small molecules
  • Mechanism of Action GABA B receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Preclinical Overactive bladder; Urinary calculi

Most Recent Events

  • 26 Oct 2016 Preclinical trials in Overactive bladder in USA (Parenteral) before October 2016 (OptMed pipeline, October 2016)
  • 26 Oct 2016 Preclinical trials in Urinary calculi in USA (Parenteral) before October 2016 (OptMed pipeline, October 2016)
  • 26 Oct 2016 OptMed files for patent protection for re-purposed diazepam in USA before October 2016 (OptMed website, October 2016)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top